News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Aakash Desai Shared A Study Published In JTO on Datopotamab Deruxtecan In Patients With EGFR-mutated NSCLC
Aakash Desai/LinkedIn
Jun 17, 2025, 06:18

Aakash Desai Shared A Study Published In JTO on Datopotamab Deruxtecan In Patients With EGFR-mutated NSCLC

Aakash Desai, Assistant Professor and Associate Director of Phase 1 and Precision Oncology Program at the UAB O’Neal Comprehensive Cancer Center, posted on X:

“A pooled analysis of datopotamab deruxtecan in patients with EGFR-mutated NSCLC – Journal of Thoracic Oncology.
Interesting analysis ahead of the U.S. FDA.
PDUFA date: July 12, 2025
Will we see another option in EGFRm NSCLC?” 

Datopotamab

Title: A pooled analysis of datopotamab deruxtecan in patients with EGFR-mutated NSCLC

Journal: Journal of Thoracic Oncology

Authors: Myung-Ju Ahn, Aaron Lisberg, Yasushi Goto, Jacob Sands, Min Hee Hong, Luis Paz-Ares, Elvire Pons-Tostivint, Maurice Pérol, Enriqueta Felip, Shunichi Sugawara, Hidetoshi Hayashi, Byoung Chul Cho, George Blumenschein Jr., Elaine Shum, Jong-Seok Lee, Rebecca S. Heist, Robin Cornelissen, Wen-Cheng Chang, Dariusz Kowalski, Hong Zebger-Gong, Michael Chargualaf, Wen Gu, Lan Lan, Paul Howarth, Richard Joseph, Isamu Okamoto

Read the full article.

Datopotamab

More posts featuring Aakash Desai on OncoDaily.

Aakash Desai Aaron Lisberg Byoung Chul Cho cancer Dariusz Kowalski datopotamab deruxtecan EGFR-mutated NSCLC Elaine Shum Elvire Pons-Tostivint Enriqueta Felip FDA George Blumenschein Jr Hidetoshi Hayashi Hong Zebger-Gong Isamu Okamoto Jacob Sands Jong-Seok Lee Journal of Thoracic Oncology Lan Lan Luis Paz-Ares Maurice Pérol Michael Chargualaf Min Hee Hong Myung-Ju Ahn OncoDaily Oncology Paul Howarth PDUFA date Rebecca S. Heist Richard Joseph Robin Cornelissen Shunichi Sugawara U.S. FDA UAB O'Neal Comprehensive Cancer Center Wen Gu Wen-Cheng Chang Yasushi Goto
Special Coverage
Insight
Jun 17, 2025, 06:18
Aakash Desai Shared A Study Published In JTO on Datopotamab Deruxtecan In Patients With EGFR-mutated NSCLC
Blog
Jun 17, 2025, 06:16
Nirmala Bhoo Pathy: Transforming Chronic Disease Care through Patient and Financial Navigation Training Seminar
Blog
Jun 17, 2025, 06:11
Bruno Larvol: Back to Times Square - Celebrating Oncologists
Blog
Jun 17, 2025, 05:29
Nirmala Bhoo Pathy: Important talk on regional procurement of game-changing (cancer) drugs and therapies across Association of Southeast Asian Nations
Insight
Jun 17, 2025, 05:20
Patrick Hwu: How can we help CAR T cells survive longer and fight tumors more effectively?
Blog
Jun 17, 2025, 05:08
Milan Mishkovikj: Proud to ba at the high-level policy event - Connecting the Dots: Obesity, Digestive Diseases, and Cancers
Career
Jun 17, 2025, 04:46
Olubukola Ayodele: Congratulations to Bola Owolabi on being awarded a Commander of the Order of the British Empire
Insight
Jun 17, 2025, 03:51
Youth Cancer Europe Hosts Stakeholder Forum on Equity, Diversity and Inclusion in Cancer Care
Societies
Jun 16, 2025, 18:35
25 Posts Not to Miss from EHA 2025
Science
Jun 16, 2025, 17:06
Carmen Criscitiello Highlights Strategies to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer
Career
Jun 16, 2025, 16:15
Congratulations to the 2025 Young Investigator Award Winners - SIOP
Blog
Jun 16, 2025, 16:02
Naveen Pemmaraju Highlighted Musa Yilmaz's EHA 2025 Presentation on DEC/VEN/QUIZ in FLT3-ITD AML